GeoWealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
GeoWealth Management's ABBV Position: Q2 2026 in Review
GeoWealth Management increased its AbbVie (ABBV) stake by 3% in Q2 2026, buying an estimated $91.4K and bringing the position to 14,601 shares worth $3.67M. The position accounts for 0.12% of the portfolio, ranked #107.
GeoWealth Management first reported a position in ABBV in Q2 2021 and has held it in 21 quarters since. The position peaked at $4.21M in Q1 2024. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- GeoWealth Management held 14,601 shares of AbbVie worth $3.67M as of Q2 2026.
- GeoWealth Management bought 425 AbbVie shares in Q2 2026, an estimated $91.4K.
- AbbVie made up 0.12% of GeoWealth Management's portfolio in Q2 2026, its #107 holding.
- GeoWealth Management first reported a position in AbbVie in Q2 2021 and has held it in 21 quarters since.
- GeoWealth Management's AbbVie position peaked at $4.21M in Q1 2024.
- 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on GeoWealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.